In a recent transaction, Derica W. Rice, an executive at Bristol-Myers Squibb (BMY), executed a stock transaction on September 30, 2024. The details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the transaction, have not been disclosed. The transaction has been reported in compliance with regulatory requirements, and the current number of shares held by Rice after the transaction remains unspecified.

In a recent transaction, Derica W. Rice, an executive at Bristol-Myers Squibb (BMY), executed a stock transaction on September 30, 2024. The details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the transaction, have not been disclosed. The transaction has been reported in compliance with regulatory requirements, and the current number of shares held by Rice after the transaction remains unspecified.